Literature DB >> 1583133

Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor.

R P Verkooyen1, M A Hazenberg, G H Van Haaren, J M Van Den Bosch, R J Snijder, H P Van Helden, H A Verbrugh.   

Abstract

Microimmunofluorescence (MIF) serology is commonly used in the diagnosis of chlamydial infections. In the MIF assay, Chlamydia pneumoniae elementary bodies were used to detect C. pneumoniae immunoglobulin G (IgG) and IgM antibodies in paired serum samples from 286 patients with respiratory illnesses. In 69 patients, MIF serology was compared with C. pneumoniae cultures. All C. pneumoniae cultures remained negative. However, 205 (71%) of 286 patients were C. pneumoniae antibody positive and 64 (22%) had MIF test results indicating recent infection; 11 showed a fourfold increase in IgG titer, 18 had IgG titers of greater than or equal to 1:512, and 41 had IgM titers of greater than or equal to 1:16. In 35 (55%) of 64 patients, a recent-infection diagnosis was based on C. pneumoniae IgM antibodies only. However, 78% of C. pneumoniae IgM-positive patients had circulating rheumatoid factor (RF) by rheumatoid arthritis latex assay. RF positivity increased with age. After absorption with anti-human IgG, all C. pneumoniae IgM-positive sera became C. pneumoniae IgM negative in the MIF assay. Twenty-five patients with active rheumatoid arthritis but without respiratory illness were also tested; 14 were C. pneumoniae IgG positive and C. pneumoniae IgM positive as well. Absorption of IgG from these RF-containing sera invariably resulted in disappearance of reactivity in the MIF IgM assay. We conclude that with age the serologic diagnosis of recent C. pneumoniae infection becomes increasingly prone to false-positive results unless sera are routinely absorbed prior to MIF IgM testing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583133      PMCID: PMC265266          DOI: 10.1128/jcm.30.5.1287-1290.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium.

Authors:  L Van Renterghem; A M Van den Abeele; G Claeys; J Plum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

2.  Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  L D Cles; W E Stamm
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 3.  Development of rheumatoid factor research through 50 years.

Authors:  F Milgrom
Journal:  Scand J Rheumatol Suppl       Date:  1988

4.  Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically.

Authors:  J T Grayston; V K Diwan; M Cooney; S P Wang
Journal:  Arch Intern Med       Date:  1989-01

5.  The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria.

Authors:  M Nurminen; M Leinonen; P Saikku; P H Mäkelä
Journal:  Science       Date:  1983-06-17       Impact factor: 47.728

6.  Distribution of rheumatoid factor activity in nonrheumatoid states.

Authors:  H Bartfeld
Journal:  Ann N Y Acad Sci       Date:  1969-12-10       Impact factor: 5.691

7.  Immune response to genital chlamydial infection and influence of Chlamydia pneumoniae (TWAR) antibodies.

Authors:  S Osser; K Persson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

8.  Do polyclonal rheumatoid factors carry an 'internal image' of cytomegalovirus, Epstein-Barr virus and nuclear antigens?

Authors:  J N McCormick; D Wojtacha; E Edmond; B Cohen; H Hart
Journal:  Scand J Rheumatol Suppl       Date:  1988

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

10.  Rheumatoid factor and immune networks.

Authors:  D A Carson; P P Chen; R I Fox; T J Kipps; F Jirik; R D Goldfien; G Silverman; V Radoux; S Fong
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

View more
  17 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Laboratory diagnosis of Chlamydia pneumoniae infections.

Authors:  R W Peeling
Journal:  Can J Infect Dis       Date:  1995-07

3.  Rapid and simple diagnosis of Chlamydophila pneumoniae pneumonia by an immunochromatographic test for detection of immunoglobulin M antibodies.

Authors:  Naoyuki Miyashita; Kazunobu Ouchi; Fumio Kishi; Mitsuaki Tabuchi; Naoki Tsumura; Hisaichi Bannai; Satoshi Iwata; Toshihiro Tanaka; Mikio Oka
Journal:  Clin Vaccine Immunol       Date:  2008-05-14

4.  Chlamydia pneumoniae.

Authors:  T J Marrie
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

5.  Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test.

Authors:  T Jauhiainen; T Tuomi; M Leinonen; J D Kark; P Saikku
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection.

Authors:  M Ben-Yaakov; G Eshel; L Zaksonski; Z Lazarovich; I Boldur
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

7.  Rapid homogeneous immunoassay based on time-resolved Förster resonance energy transfer for serodiagnosis of acute hantavirus infection.

Authors:  Satu Hepojoki; Jussi Hepojoki; Klaus Hedman; Olli Vapalahti; Antti Vaheri
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

8.  Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland.

Authors:  M R Ekman; M Leinonen; H Syrjälä; E Linnanmäki; P Kujala; P Saikku
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

9.  Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel.

Authors:  M Ben-Yaakov; Z Lazarovich; S Beer; A Levin; I Shoham; I Boldur
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

10.  Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies.

Authors:  Mette Bennedsen; Lene Berthelsen; Inga Lind
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.